Gagliardi S - Search Results

1

Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.

Blaney FE, Raveglia LF, Artico M, Cavagnera S, Dartois C, Farina C, Grugni M, Gagliardi S, Luttmann MA, Martinelli M, Nadler GM, Parini C, Petrillo P, Sarau HM, Scheideler MA, Hay DW, Giardina GA. Blaney FE, et al. Among authors: gagliardi s. J Med Chem. 2001 May 24;44(11):1675-89. doi: 10.1021/jm000501v. J Med Chem. 2001. PMID: 11356103

2

Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.

Giardina GA, Artico M, Cavagnera S, Cerri A, Consolandi E, Gagliardi S, Graziani D, Grugni M, Hay DW, Luttmann MA, Mena R, Raveglia LF, Rigolio R, Sarau HM, Schmidt DB, Zanoni G, Farina C. Giardina GA, et al. Among authors: gagliardi s. Farmaco. 1999 Jun 30;54(6):364-74. doi: 10.1016/s0014-827x(99)00043-9. Farmaco. 1999. PMID: 10443017

3

Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.

Gagliardi S, Rees M, Farina C. Gagliardi S, et al. Curr Med Chem. 1999 Dec;6(12):1197-212. Curr Med Chem. 1999. PMID: 10519916 Review.

4

Antagonists at the neurokinin receptors--recent patent literature.

Giardina GA, Gagliardi S, Martinelli M. Giardina GA, et al. Among authors: gagliardi s. IDrugs. 2003 Aug;6(8):758-72. IDrugs. 2003. PMID: 12917772 Review.

5

Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.

Gagliardi S, Gatti PA, Belfiore P, Zocchetti A, Clarke GD, Farina C. Gagliardi S, et al. J Med Chem. 1998 May 21;41(11):1883-93. doi: 10.1021/jm9707838. J Med Chem. 1998. PMID: 9599238

6

(2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6- pentamethylpiperidin-4-yl)-2,4-pentadienamide, a novel, potent and selective inhibitor of the osteoclast V-ATPase.

Nadler G, Morvan M, Delimoge I, Belfiore P, Zocchetti A, James I, Zembryki D, Lee-Rycakzewski E, Parini C, Consolandi E, Gagliardi S, Farina C. Nadler G, et al. Among authors: gagliardi s. Bioorg Med Chem Lett. 1998 Dec 15;8(24):3621-6. doi: 10.1016/s0960-894x(98)00660-x. Bioorg Med Chem Lett. 1998. PMID: 9934482

7

5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity.

Gagliardi S, Nadler G, Consolandi E, Parini C, Morvan M, Legave MN, Belfiore P, Zocchetti A, Clarke GD, James I, Nambi P, Gowen M, Farina C. Gagliardi S, et al. J Med Chem. 1998 May 7;41(10):1568-73. doi: 10.1021/jm9800144. J Med Chem. 1998. PMID: 9572882

8

Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain.

Farina C, Gagliardi S, Ghelardini C, Martinelli M, Norcini M, Parini C, Petrillo P, Ronzoni S. Farina C, et al. Among authors: gagliardi s. Bioorg Med Chem. 2008 Mar 15;16(6):3224-32. doi: 10.1016/j.bmc.2007.12.015. Epub 2007 Dec 15. Bioorg Med Chem. 2008. PMID: 18171618

9

Novel bone antiresorptive agents that selectively inhibit the osteoclast V-H+-ATPase.

Farina C, Gagliardi S, Nadler G, Morvan M, Parini C, Belfiore P, Visentin L, Gowen M. Farina C, et al. Among authors: gagliardi s. Farmaco. 2001 Jan-Feb;56(1-2):113-6. doi: 10.1016/s0014-827x(01)01013-8. Farmaco. 2001. PMID: 11347950 Review.

10

Synthesis of photoactivable inhibitors of osteoclast vacuolar ATPase.

Biasotti B, Dallavalle S, Merlini L, Farina C, Gagliardi S, Parini C, Belfiore P. Biasotti B, et al. Among authors: gagliardi s. Bioorg Med Chem. 2003 May 15;11(10):2247-54. doi: 10.1016/s0968-0896(03)00106-8. Bioorg Med Chem. 2003. PMID: 12713834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page